NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice

Valerio Nobili1, Matilde Marcellini, Rita Devito

  • 1Liver Unit, Bambino Gesù Children's Hospital, Rome, Italy. nobili66@yahoo.it

Insights

Pediatric nonalcoholic fatty liver disease (NAFLD) is common and often linked to insulin resistance, even in normal-weight children. Lifestyle advice significantly improves NAFLD markers in children.

Area of Science:

  • Pediatrics
  • Hepatology
  • Metabolic Disorders

Background:

  • Nonalcoholic fatty liver disease (NAFLD) is a growing concern in pediatric populations, yet its clinical presentation and management in children remain incompletely understood.
  • NAFLD in children is associated with metabolic abnormalities and can progress to liver fibrosis.

Purpose of the Study:

  • To characterize the clinical presentation of NAFLD in children.
  • To evaluate the impact of a 12-month lifestyle intervention program on pediatric NAFLD management.

Main Methods:

  • Prospective study involving 84 children (ages 3-18.8) with biopsy-confirmed NAFLD.
  • Assessment included oral glucose tolerance tests, body mass index (BMI) measurements, and metabolic markers.
  • Intervention consisted of 12 months of diet and physical exercise advice.

Main Results:

  • Most children (80%) exhibited insulin resistance, irrespective of BMI.
  • Obesity and older age were independently associated with increased liver fibrosis (OR 2.7 and 1.2, respectively).
  • The lifestyle intervention led to significant improvements in BMI, glucose, insulin, lipids, liver enzymes, and liver echogenicity.

Conclusions:

  • Pediatric NAFLD is frequently characterized by insulin resistance, even in normal-weight individuals.
  • Obesity and advanced age are risk factors for liver fibrosis in pediatric NAFLD.
  • A lifestyle advice program effectively improves metabolic and liver parameters in children with NAFLD.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...